Therapy of leptomeningeal metastasis in solid tumors.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cancer Treatment Reviews

• Publication date

  2016-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ctrv.2015.12.004PMID 26827696
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.

  2015cited by this paper
• Leptomeningeal Metastases in High-Grade Adult Glioma: Development, Diagnosis, Management, and Outcomes in a Series of 34 Patients

  2014cited by this paper
• Leptomeningeal dissemination in glioblastoma; an inspection of risk factors, treatment, and outcomes at a single institution

  2014cited by this paper
• Carcinomatous meningitis: Leptomeningeal metastases in solid tumors

  2013cited by this paper
• A retrospective case series of 103 consecutive patients with leptomeningeal metastasis and breast cancer

  2013cited by this paper
• Vemurafenib for leptomeningeal melanomatosis.

  2013cited by this paper
• Intrathecal administration of trastuzumab for the treatment of meningeal carcinomatosis in HER2-positive metastatic breast cancer: a systematic review and pooled analysis

  2013cited by this paper
• Neoplastic Meningitis: How MRI and CSF Cytology Are Influenced by CSF Cell Count and Tumor Type

  2013influential reference
• Analysis of Treatment Outcomes of Intraventricular Chemotherapy in 105 Patients for Leptomeningeal Carcinomatosis from Non–Small-Cell Lung Cancer

  2013cited by this paper
• Intrathecal Trastuzumab Treatment of the Neoplastic Meningitis due to Breast Cancer: A Case Report and Review of the Literature

  2013cited by this paper
• Clinical and radiological response of leptomeningeal melanoma after whole brain radiotherapy and ipilimumab

  2012cited by this paper
• Outcome after whole brain radiotherapy alone in intracranial leptomeningeal carcinomatosis from solid tumors

  2012cited by this paper
• Neurotoxicity of intra-CSF liposomal cytarabine (DepoCyt) administered for the treatment of leptomeningeal metastases: a retrospective case series

  2012cited by this paper
• Leptomeningeal Metastasis from Non-small Cell Lung Cancer: Survival and the Impact of Whole Brain Radiotherapy

  2012cited by this paper
• Neoplastic meningitis.

  2012cited by this paper
• EGFR mutation status in brain metastases of non-small cell lung carcinoma

  2012cited by this paper
• Neoplastic leptomeningitis presenting in a melanoma patient treated with dabrafenib (a V600EBRAF inhibitor): a case report

  2012cited by this paper
• Benefit of ventriculoperitoneal cerebrospinal fluid shunting and intrathecal chemotherapy in neoplastic meningitis: a retrospective, case-controlled study.

  2011cited by this paper
• Ventriculoperitoneal shunt for hydrocephalus caused by central nervous system metastasis

  2011cited by this paper
• Central nervous system cancers.

  2011cited by this paper
• "Pulsatile" high-dose weekly erlotinib for CNS metastases from EGFR mutant non-small cell lung cancer.

  2011cited by this paper
• Leptomeningeal disease.

  2011cited by this paper
• Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma.

  2011cited by this paper
• Neoplastic meningitis.

  2011cited by this paper
• Malignant cells in cerebrospinal fluid (CSF): The meaning of a positive CSF cytology

  2011cited by this paper
• Neurologic complications after intrathecal liposomal cytarabine in combination with systemic polychemotherapy in primary CNS lymphoma

  2011cited by this paper
• Leptomeningeal melanomatosis: Stabilization of disease due to radiation, temozolomide and intrathecal liposomal cytarabine

  2011cited by this paper
• Clinical Recommendations of DEGRO and AGO on Preferred Standard Palliative Radiotherapy of Bone and Cerebral Metastases, Metastatic Spinal Cord Compression, and Leptomeningeal Carcinomatosis in Breast Cancer

  2010cited by this paper
• Prognostic factors and treatment options in patients with leptomeningeal metastases of different primary tumors: a retrospective analysis

  2010cited by this paper
• Neoplastic meningitis (Journal of Clinical Oncology (2005) 23 (3605-3613))

  2010cited by this paper
• Route of intracerebrospinal fluid chemotherapy administration and efficacy of therapy in neoplastic meningitis

  2010cited by this paper
• High dose weekly erlotinib achieves therapeutic concentrations in CSF and is effective in leptomeningeal metastases from epidermal growth factor receptor mutant lung cancer

  2010cited by this paper
• Carcinoembryonic antigen in the CSF of cancer patients--the value of intrathecal synthesis and correlation with IgA-diffusion dynamics.

  2010cited by this paper
• Intrathecal chemotherapy for treatment of leptomeningeal dissemination of metastatic tumours.

  2010cited by this paper
• Dosimetric comparison of conventional helmet-field whole-brain irradiation with three-dimensional conformal radiotherapy: dose homogeneity and retro-orbital area coverage.

  2009cited by this paper
• Treatment modalities for leptomeningeal metastases.

  2009cited by this paper
• Carcinomatous meningitis in non-small-cell lung cancer: response to high-dose erlotinib.

  2009cited by this paper
• Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma

  2009cited by this paper
• Recurrent lymphomatous meningitis treated with intra-CSF rituximab and liposomal ara-C

  2009cited by this paper
• Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis

  2008cited by this paper
• A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies.

  2008cited by this paper
• P 3 – Hirnmetastasen und Meningeosis neoplastica

  2007cited by this paper
• Neurologic complications associated with intrathecal liposomal cytarabine given prophylactically in combination with high-dose methotrexate and cytarabine to patients with acute lymphocytic leukemia.

  2007cited by this paper
• Phase II trial of intracerebrospinal fluid etoposide in the treatment of neoplastic meningitis

  2006cited by this paper
• Chemotherapy in neoplastic meningitis.

  2006cited by this paper
• Response and resistance in a non-small-cell lung cancer patient with an epidermal growth factor receptor mutation and leptomeningeal metastases treated with high-dose gefitinib.

  2006cited by this paper
• Effect of prophylactic cranial irradiation dose on CNS relapse, late cognitive decline and learning disabilities in children treated for acute lymphoblastic leukemia.

  2006cited by this paper
• Intrathecal topotecan in adult patients with neoplastic meningitis.

  2006cited by this paper
• Neoplastic meningitis.

  2005cited by this paper
• Intrathecal mafosfamide: a preclinical pharmacology and phase I trial.

  2005cited by this paper
• Central nervous system cancers: Clinical Practice Guidelines in Oncology.

  2005cited by this paper
• Leptomeningeal Metastasis

  2005cited by this paper
• An Open Label Trial of Sustained-release Cytarabine (DepoCyt™) for the Intrathecal Treatment of Solid Tumor Neoplastic Meningitis

  2004cited by this paper
• The relevance of intraventricular chemotherapy for leptomeningeal metastasis in breast cancer: a randomised study.

  2004cited by this paper
• Neoplastic Meningitis

  2004cited by this paper
• Leptomeningeal metastasis: survival and prognostic factors in 155 patients.

  2004influential reference
• Systemic chemotherapy, intrathecal chemotherapy, and symptom management in the treatment of leptomeningeal metastasis

  2003cited by this paper
• Diagnosis and management of central nervous system metastases from breast cancer.

  2003cited by this paper
• Central nervous system metastases in women who receive trastuzumab‐based therapy for metastatic breast carcinoma

  2003influential reference
• Medulloblastomas: clinical profile, treatment techniques and outcome - an institutional experience.

  2002cited by this paper
• Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine

  2001cited by this paper
• A comparison between ventricular and lumbar cerebrospinal fluid cytology in adult patients with leptomeningeal metastases.

  2001cited by this paper
• Does the standardized helmet technique lead to adequate coverage of the cribriform plate? An analysis of current practice with respect to the ICRU 50 report.

  2001cited by this paper
• Detection of rare malignant cells and their apoptotic fragments in cerebrospinal fluid.

  2000cited by this paper
• A randomized controlled trial comparing intrathecal sustained-release cytarabine (DepoCyt) to intrathecal methotrexate in patients with neoplastic meningitis from solid tumors.

  1999cited by this paper
• Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis.

  1999influential reference
• Carcinoma meningitis secondary to non-small cell lung cancer: combined modality therapy.

  1998cited by this paper
• High-dose intravenous methotrexate for patients with nonleukemic leptomeningeal cancer: is intrathecal chemotherapy necessary?

  1998cited by this paper
• Current diagnosis and treatment of leptomeningeal metastasis

  1998influential reference
• Leptomeningeal metastases from solid tumors

  1998cited by this paper
• Carcinomatous meningitis secondary to breast cancer: Predictors of response to combined modality therapy

  1997cited by this paper
• Leptomeningeal metastases due to melanoma.

  1996cited by this paper
• Prognostic significance of sup 111 Indium-DTPA CSF flow studies in leptomeningeal metastases

  1996cited by this paper
• Leptomeningeal Carcinomatosis: Presenting Features and Prognostic Factors

  1996cited by this paper
• Leptomeningeal carcinomatosis. Presenting features and prognostic factors.

  1996cited by this paper
• Diagnosis, management, and survival of patients with leptomeningeal cancer based on cerebrospinal fluid‐flow status

  1995cited by this paper
• Is the standardized helmet technique adequate for irradiation of the brain and the cranial meninges?

  1995cited by this paper
• Frequency of unexplained meningeal enhancement in the brain after lumbar puncture.

  1994cited by this paper
• Clinical outcome in aggressively treated meningeal carcinomatosis.

  1994cited by this paper
• Liposomes as carriers of cancer chemotherapy. Current status and future prospects.

  1993cited by this paper
• Liposomes as Carriers of Cancer Chemotherapy

  1993cited by this paper
• Leptomeningeal metastasis

  1993cited by this paper
• Meningeal carcinomatosis in breast cancer. Prognostic factors and influence of treatment

  1991cited by this paper
• The risks of metastases from shunting in children with primary central nervous system tumors.

  1991cited by this paper
• Leptomeningeal metastases: Comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias

  1990influential reference
• Brain stem and spinal metastases of supratentorial glioblastoma multiforme: a clinical series.

  1990cited by this paper
• High-dose etoposide for meningeal carcinomatosis in patients with small cell lung cancer.

  1989cited by this paper
• Combination intraventricular chemotherapy for meningeal neoplasia.

  1986cited by this paper
• Intraventricular methotrexate therapy of leptomeningeal metastasis from breast carcinoma

  1983cited by this paper
• Meningeal carcinomatosis in small cell carcinoma of the lung.

  1982cited by this paper
• Diagnosis and treatment of leptomeningeal metastases from solid tumors: Experience with 90 patients

  1982influential reference
• Meningeal carcinomatosis in small cell carcinoma of the lung.

  1981cited by this paper
• Meningeal gliomatosis: A review of 12 cases

  1980cited by this paper
• Leukoencephalopathy and elevated levels of myelin basic protein in the cerebrospinal fluid of patients with acute lymphoblastic leukemia.

  1980cited by this paper
• Malignant cells in cerebrospinal fluid (CSF)

  1979cited by this paper
• Intracranial metastases from systemic cancer.

  1978cited by this paper
• Spinal subarachnoid metastasis from primary intracranial glioblastoma multiforme

  1978cited by this paper
• Meningeal carcinomatosis in breast cancer

  1978cited by this paper
• Malignant melanoma and central nervous system metastases. Incidence, diagnosis, treatment and survival

  1978cited by this paper
• Treatment of malignant meningeal disease with intrathecal thioTEPA: a phase II study.

  1977cited by this paper

• CSF proteomics identifies ADGRG1 as a predictive biomarker of intrathecal immune checkpoint inhibitor response in leptomeningeal metastasis

  2026cites this paper
• Leptomeningeal breast cancer metastases: clinical and cytological features on the background of intrathecal methotrexate therapy

  2025cites this paper
• Treatment strategies for leptomeningeal disease in patients with breast cancer.

  2025cites this paper
• Isolated Leptomeningeal Carcinomatosis in Urothelial Carcinoma: A Case Report of Positive CSF Cytology With Negative Imaging

  2025cites this paper
• Leptomeningeal Metastasis, an Evolving Frontier for Radiation Oncology.

  2025cites this paper
• Curvilinear Peri-Brainstem Hyperintense Signals as a Marker of Leptomeningeal Metastases in Lung Adenocarcinoma: A Multicenter Retrospective Case Series.

  2025cites this paper
• Cerebrospinal fluid seeding from pediatric intra and extra-cranial tumors: optimization of the MRI protocol

  2025cites this paper
• Leptomeningeal Carcinomatosis and Myelophthisic Anemia as Initial Manifestations of Metastatic Lobular Breast Cancer

  2025cites this paper
• Leptomeningeal Metastasis from Cervix Squamous-Cell Carcinoma: A Case Report and Review of Literature

  2025cites this paper
• Gut microbiota and metabolite features in NSCLC nude mouse models of subcutaneous tumor and leptomeningeal metastasis: a microbiome-metabolome combined analysis

  2025cites this paper
• Meningeal mass revealing undifferentiated renal carcinoma: A case report

  2025cites this paper
• The efficacy and safety of intrathecal pemetrexed for leptomeningeal metastasis from non-small cell lung cancer: a single-arm meta-analysis of Chinese patients

  2025cites this paper
• Longitudinal CSF Tumor Cell Enumeration and Mutational Analysis as a Driver for Leptomeningeal Disease Management

  2025cites this paper
• Efficacy and safety of aumolertinib in EGFR-mutated non-small cell lung cancer with leptomeningeal metastasis: a single‑center retrospective study

  2025cites this paper
• Meningeal Metastasis from Naso-Ethmoidal Malignancies: Pathogenesis, Risk Factors, and Prognostic Impact

  2025cites this paper
• Isolated symmetric internal auditory canal enhancement in leptomeningeal carcinomatosis from gastric cancer

  2025cites this paper
• New Breakthroughs in the Diagnosis of Leptomeningeal Carcinomatosis: A Review of Liquid Biopsies of Cerebrospinal Fluid

  2024cites this paper
• Intrathecal anti-PD-1 treatment in metastatic melanoma patients with leptomeningeal disease (LMD): real-world data and evidence

  2024cites this paper
• Top Ten Tips Palliative Care Clinicians Should Know About Caring for People with Leptomeningeal Disease

  2024cites this paper
• Patients with Leptomeningeal Carcinomatosis and Hydrocephalus-Feasibility of Combined Ventriculoperitoneal Shunt and Reservoir Insertion for Intrathecal Chemotherapy

  2024cites this paper
• PROTAC EZH2 degrader-1 overcomes the resistance of podophyllotoxin derivatives in refractory small cell lung cancer with leptomeningeal metastasis

  2024cites this paper
• Treatment Advances in Lung Cancer with Leptomeningeal Metastasis.

  2024cites this paper
• Efficacy of hypofractionated Gamma Knife radiosurgery in treating surgical beds of metastatic brain tumors.

  2024cites this paper
• A Phase II Study of Concurrent Involved-field Radiotherapy and Intrathecal Chemotherapy for Leptomeningeal Metastasis from Solid Tumors.

  2023cites this paper
• Radiation Therapy in the Management of Leptomeningeal Disease From Solid Tumors

  2023cites this paper
• Engineering choroid plexus-on-a-chip with oscillatory flow for modeling brain metastasis

  2023cites this paper
• Neurologic pathologies of the vertebral spine

  2023cites this paper
• Diagnostic and Therapeutic Updates in Leptomeningeal Disease

  2023cites this paper
• Cerebrospinal fluid protein levels are elevated 100 times in a Leptomeningeal metastasis patient: a case report and literature review

  2023cites this paper
• Research development of porphyrin-based metal-organic frameworks: targeting modalities and cancer therapeutic applications.

  2023cites this paper
• Leptomeningeal metastasis in primary uterine cervical cancer: a rare case and review of the literature

  2023cites this paper
• Guillain-Barre Syndrome, a Leptomeningeal Metastasis Mimic, in a Patient With Metastatic Breast Carcinoma

  2023cites this paper
• Leptomeningeal dissemination in pediatric brain tumors.

  2023cites this paper
• Leptomeningeal Disease (LMD) in Patients with Melanoma Metastases

  2023cites this paper
• Osimertinib Improves overall survival of EGFR-mutant NSCLC patients with leptomeningeal metastases

  2023cites this paper
• Risk of leptomeningeal metastasis in children with parameningeal rhabdomyosarcoma with intracranial spread

  2023cites this paper
• Collagen deposition within brain metastases is associated with leptomeningeal failure after 
cavity-directed radiosurgery

  2023cites this paper
• Systemic Therapy for Melanoma Brain and Leptomeningeal Metastases

  2023cites this paper
• An overview of the therapeutic strategies for neoplastic meningitis due to breast cancer: when and why?

  2023cites this paper
• Therapeutic role of EGFR - Tyrosine kinase inhibitors in non-small cell lung cancer with leptomeningeal metastasis

  2023influential citation
• Leptomeningeal spread in high-grade gliomas: Is surgery or adjuvant therapy after leptomeningeal spread associated with survival benefit?

  2023cites this paper
• Intrathecal Therapy Options for Meningeal Carcinomatosis

  2023cites this paper
• A Case of Leptomeningeal Carcinomatosis Manifesting With Vertigo in the Setting of Intracranial Hypertension

  2023cites this paper
• Intraventricular SHH inhibition proves efficient in SHH medulloblastoma mouse model and prevents systemic side effects.

  2023cites this paper
• Long survival of a patient with leptomeningeal infiltration in breast cancer: A case report

  2022cites this paper
• Leptomeningeal Carcinomatosis in a Patient with Pancreatic Cancer: A Rare Phenomenon?

  2022cites this paper
• Randomized Phase II Trial of Proton Craniospinal Irradiation Versus Photon Involved-Field Radiotherapy for Patients With Solid Tumor Leptomeningeal Metastasis

  2022cites this paper
• Noninvasive ultrasonic induction of cerebrospinal fluid flow enhances intrathecal drug delivery.

  2022cites this paper
• Isolated Leptomeningeal Metastasis of Breast Cancer During Neo-Adjuvant Chemotherapy: A Case Report

  2022cites this paper
• The joint detection of CEA and ctDNA in cerebrospinal fluid: an auxiliary tool for the diagnosis of leptomeningeal metastases in cancer

  2022cites this paper
• Neurological Complications of Intrathecal Chemotherapy in Children: Experience in A Tertiary Care Hospital in Bangladesh

  2022cites this paper
• Engineering Metalloporphyrin-Integrated Nanosystems for Targeted Sono-/Chemo- Dynamic Therapy of Leptomeningeal Carcinomatosis through Intrathecal Administration

  2022cites this paper
• Leptomeningeal Metastases of the Spine: A Systematic Review

  2022cites this paper
• Deciphering Biomarkers for Leptomeningeal Metastasis in Malignant Hemopathies (Lymphoma/Leukemia) Patients by Comprehensive Multipronged Proteomics Characterization of Cerebrospinal Fluid

  2022cites this paper
• Leptomeningeal metastasis in patients with non-small cell lung cancer after stereotactic radiosurgery for brain metastasis.

  2022cites this paper
• Clinical Outcome of Neoplastic Meningitis Associated with Breast Cancer

  2022cites this paper
• 肺癌脑膜转移癌诊疗的研究进展

  2022cites this paper
• Assessment of Leptomeningeal Carcinomatosis Diagnosis, Management and Outcomes in Patients with Solid Tumors Over a Decade of Experience.

  2021influential citation
• Leptomeningeal disease in pancreas ductal adenocarcinoma: A manifestation of longevity.

  2021cites this paper
• Anti-EGFR VHH-armed death receptor ligand–engineered allogeneic stem cells have therapeutic efficacy in diverse brain metastatic breast cancers

  2021cites this paper
• Leptomeningeal disease from melanoma-Poor prognosis despite new therapeutic modalities.

  2021cites this paper
• Inhibition of Jumonji Histone Demethylases Selectively Suppresses HER2+ Breast Leptomeningeal Carcinomatosis Growth via Inhibition of GMCSF Expression

  2021cites this paper
• Leptomeningeal carcinomatosis from gallbladder cancer after curative resection: A case report and review of literature

  2021cites this paper
• Persistent follicular granulosa cell senescence and apoptosis induced by methotrexate leading to oocyte dysfunction and aberrant embryo development

  2021cites this paper
• Unusual case of long survival patient with leptomeningeal carcinomatosis from breast cancer

  2021cites this paper
• Autocrine GMCSF Signaling Contributes to Growth of HER2+ Breast Leptomeningeal Carcinomatosis

  2021cites this paper
• Advances in targeted therapy in non‐small cell lung cancer with actionable mutations and leptomeningeal metastasis

  2021cites this paper
• Efficacy of osimertinib for preventing leptomeningeal metastasis derived from advanced EGFR-mutated non-small cell lung cancer: a propensity-matched retrospective study

  2021cites this paper
• Pembrolizumab for patients with leptomeningeal metastasis from solid tumors: efficacy, safety, and cerebrospinal fluid biomarkers

  2021cites this paper
• Clinical efficacy and safety of different doses of intrathecal methotrexate in the treatment of leptomeningeal carcinomatosis: a prospective and single-arm study.

  2021cites this paper
• Neoplastic meningitis in solid tumours: updated review of diagnosis, prognosis, therapeutic management, and future directions.

  2021cites this paper
• Leptomeningeal carcinomatosis and breast cancer: a systematic review of current evidence on diagnosis, treatment and prognosis

  2021cites this paper
• Combination treatment with bevacizumab plus erlotinib for meningeal carcinomatosis of afatinib-resistant EGFR mutated lung cancer without T790M mutation: a case report.

  2021cites this paper
• Associations of meaning of illness with psychosocial, clinical, and immunological characteristics in patients with Leptomeningeal metastasis

  2021cites this paper
• Leptomeningeal Metastases From Colorectal Signet-Ring Cell Cancer: A Case Report and Literature Review.

  2021cites this paper
• Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment

  2021cites this paper
• Cerebrospinal fluid as a medium of liquid biopsy in the management of patients with non-small-cell lung cancer having central nervous system metastasis.

  2021cites this paper
• Leptomeningeal Carcinomatosis

  2021cites this paper
• Neoplastic meningitis in solid tumours: Updated review of diagnosis, prognosis, therapeutic management, and future directions.

  2020cites this paper
• High Cell-Free DNA Levels in Cerebrospinal Fluid Predict Leptomeningeal Seeding of Hematologic Malignancy

  2020cites this paper
• Leptomeningeal Carcinomatosis: Challenges in Diagnosis and Treatment

  2020cites this paper
• Diagnosing Primary Malignancy in Leptomeningeal Carcinomatosis by Using CSF Cytology and Immunohistochemistry: A Case Report

  2020cites this paper
• GM-CSF signaling is critical for HER2+ breast leptomeningeal carcinomatosis

  2020cites this paper
• Brain Metastases and Neoplastic Meningitis

  2020cites this paper
• Health care resource utilization and treatment of leptomeningeal carcinomatosis in the United States.

  2020cites this paper
• T2-SPACE imaging of the cauda equina for the assessment of leptomeningeal metastatic disease.

  2020cites this paper
• Leptomeningeal Disease as a Rare Complication of Primary Penile Urethral Cancer

  2020cites this paper
• Intradurale, extramedulläre Tumore: Epidemiologie, Diagnostik und Therapie

  2020cites this paper
• [Auxiliary Diagnostic Value of Tumor Markers in the Cerebrospinal Fluid and Blood for Leptomeningeal Metastasis from Non-small Cell Lung Cancer].

  2020cites this paper
• αvβ8 integrin adhesion and signaling pathways in development, physiology and disease

  2020cites this paper
• Clinical Trial of Proton Craniospinal Irradiation for Leptomeningeal Metastases.

  2020cites this paper
• Therapeutic management of neuro-oncologic patients - potential relevance of CSF liquid biopsy

  2020cites this paper
• Noninvasive Ultrasonic Glymphatic Induction Enhances Intrathecal Drug Delivery

  2020cites this paper
• Knockdown of IKKβ Inhibits Tumor Development in a Leptomeningeal Metastasis Mouse Model and Proliferation of Lung Cancer Cells

  2020cites this paper
• Leptomeningeal Carcinomatosis: Molecular Landscape, Current Management, and Emerging Therapies.

  2020cites this paper
• An overview of leptomeningeal disease.

  2020cites this paper
• A molecular graded prognostic assessment (molGPA) model specific for estimating survival in lung cancer patients with leptomeningeal metastases.

  2019cites this paper
• Leptomeningeal Carcinomatosis Associated with Gall Bladder Carcinoma: a Case Report and Review of Literature

  2019cites this paper
• Osimertinib for patients with leptomeningeal metastases associated with epidermal growth factor receptor T790M positive advanced NSCLC: the AURA LM analysis.

  2019cites this paper
• Stereotactic radiosurgery for resected brain metastases: single-institutional experience of over 500 cavities.

  2019cites this paper